Chemours has retired 17.8% of its shares since 2016, from 183,153,218 to 150,498,995.
At $12.74 a share, a market value of $1.9B. P/E n/m, trailing twelve months to June 2026.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 2015 | 2016-02-19 | 181,376,949 | 10-K | |
| 2016 | 2017-02-14 | 183,153,218 | 10-K | |
| 2017 | 2018-02-13 | 182,524,068 | 10-K | |
| 2018 | 2019-02-11 | 167,037,003 | 10-K | |
| 2019 | 2020-02-10 | 164,006,272 | 10-K | |
| 2020 | 2021-02-08 | 165,171,934 | 10-K | |
| 2021 | 2022-02-07 | 160,018,312 | 10-K | |
| 2022 | 2023-02-06 | 148,335,834 | 10-K | |
| 2023 | 2024-03-22 | 148,801,731 | 10-K | |
| 2024 | 2025-02-12 | 149,440,788 | 10-K | |
| 2025 | 2026-02-18 | 150,085,308 | 10-K |
Source: all 10-K filings of Chemours on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Only enough to stand still. The share count is roughly flat over the last twelve months, at 150,498,995 as of July 30, 2026. Over five years the share count is down 7.6%.
Net of every new share it issued, Chemours has 32.7 million fewer shares than at its 2016 peak. That is 17.8% of the company.
150,498,995 shares, as of July 30, 2026, from the cover page of its latest 10-Q. At the 2016 peak it had 183,153,218.
Each share is a bigger slice of the company. Someone who held Chemours stock in 2016 owns 1.2 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
Chemours ranks No. 393 of 467 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Sensata Technologies Holding (18.2%), Sba Communications (17.9%), Ofg Bancorp (17.8%), Howmet Aerospace (17.8%).
Every answer is computed from Chemours' own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
The numbers say what happened. The story says whether it can continue. We cover companies like Chemours in depth on Cannibal Stocks.
Read Cannibal Stocks